1. Home
  2. CMTL vs KZIA Comparison

CMTL vs KZIA Comparison

Compare CMTL & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comtech Telecommunications Corp.

CMTL

Comtech Telecommunications Corp.

HOLD

Current Price

$3.85

Market Cap

109.7M

Sector

Technology

ML Signal

HOLD

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

HOLD

Current Price

$13.55

Market Cap

100.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMTL
KZIA
Founded
1967
1994
Country
United States
Australia
Employees
1385
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
109.7M
100.8M
IPO Year
2024
2002

Fundamental Metrics

Financial Performance
Metric
CMTL
KZIA
Price
$3.85
$13.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$6.00
$19.50
AVG Volume (30 Days)
171.2K
237.0K
Earning Date
06-08-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$499,528,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.71
$3.24
52 Week High
$6.21
$17.40

Technical Indicators

Market Signals
Indicator
CMTL
KZIA
Relative Strength Index (RSI) 49.27 62.22
Support Level $2.78 $5.71
Resistance Level $4.24 $14.42
Average True Range (ATR) 0.21 1.08
MACD 0.03 -0.09
Stochastic Oscillator 64.66 58.33

Price Performance

Historical Comparison
CMTL
KZIA

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of communications technology and solutions. It operates in two reportable business segments: Satellite and Space Communications and Allerium. The company's Satellite and Space Communications segment, which generates maximum revenue, is organized into four technology areas: satellite modem and amplifier technologies, troposcatter technologies, cybersecurity training, and space components. This segment designs and manufactures modems, amplifiers, traveling wave tube amplifiers, frequency converters, and offers other associated software and services. The Allerium segment provides next-generation 911 (NG-911) infrastructure and solutions for state and local governments and carriers. Geographically, the company derives its key revenue from the USA.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Share on Social Networks: